Skip to main content
Medical information Clinical review pending

Transplant Testing

HLA T B Cell Lymphocyte Crossmatch Test

The HLA T B Cell Lymphocyte Crossmatch Test assesses compatibility between organ donors and recipients to minimize the risk of transplant rejection. Essential for solid organ transplantation.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Recipient: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 3 mL (2 mL min.) serum from 1 SST. Donor: 12 mL (10 mL min.) whole blood in 2 Yellow Top (ACD) tubes. Collect recipient specimen preferably 48 hours after dialysis. Ship donor sample refrigerated. DO NOT FREEZE.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. A doctor’s prescription on letterhead with a stamp and 1 photograph each of the recipient and donor is mandatory. A brief history in the Solid Organ Transplant Consent form (Form 33) is also required.
Test priceKSh 20,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the HLA T B Cell Lymphocyte Crossmatch Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Patients undergoing solid organ transplantation
  • ✓Individuals with a history of previous transplants
  • ✓Patients sensitized to HLA antigens
  • ✓Evaluation of potential transplant rejection
  • ✓High-risk transplant candidates
02

In plain language

What this test helps you understand

This test helps determine the compatibility between a potential organ donor and recipient, predicting the risk of immune-mediated rejection after transplantation. It guides clinical decisions regarding transplant suitability and management.
The HLA T B Cell Lymphocyte Crossmatch Test is a vital diagnostic tool used to assess the compatibility between organ donors and recipients. This test plays a crucial role in the field of transplantation, helping to minimize the risk of organ rejection following a transplant procedure. By determining the presence of antibodies that may react against the donor's cells, this test ensures that the best possible match is made for successful transplantation.

This test specifically measures the presence of T and B lymphocytes in the recipient's blood that may react against the donor's human leukocyte antigens (HLA). A positive crossmatch indicates that the recipient's immune system may reject the transplanted organ, while a negative crossmatch suggests compatibility.

Understanding Your Results Results from the HLA T B Cell Lymphocyte Crossmatch Test will indicate whether the recipient's immune system is likely to accept or reject the donor organ. A negative result is favorable, suggesting compatibility, while a positive result may require further evaluation and consideration of alternative donors.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. A doctor’s prescription on letterhead with a stamp and 1 photograph each of the recipient and donor is mandatory. A brief history in the Solid Organ Transplant Consent form (Form 33) is also required.
SampleRecipient: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 3 mL (2 mL min.) serum from 1 SST. Donor: 12 mL (10 mL min.) whole blood in 2 Yellow Top (ACD) tubes. Collect recipient specimen preferably 48 hours after dialysis. Ship donor sample refrigerated. DO NOT FREEZE.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
A negative crossmatch does not guarantee the absence of rejection, as other immune mechanisms can be involved. A positive crossmatch indicates a high risk of rejection and may preclude transplantation.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test checks if a recipient's immune system will react against a potential donor's organ, helping to predict the risk of transplant rejection.
It helps ensure the best possible match between donor and recipient, significantly reducing the chances of the body rejecting the new organ.
A negative result suggests compatibility and a lower risk of rejection. A positive result indicates the recipient's immune system may attack the donor organ, increasing rejection risk.
Blood samples are required from both the potential donor and the recipient. Specific tube types and volumes are necessary.
Confirm with the laboratory before booking.
A doctor’s prescription, photographs of the donor and recipient, and a completed Solid Organ Transplant Consent form (Form 33) are required.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp